Business Hours: Monday-Friday 9AM-6PM EST
SUPARTZ® (Italian)
$299
| Packs | Discount (%) | For each |
|---|---|---|
| 1 - 2 | - | $ 299 |
| 3 - 10 | 3.34% | $ 289 |
| 11 - 20 | 5.02% | $ 284 |
| 21+ | 6.69% | $ 279 |
Brand:
SUPARTZ®
Manufacturer:
Seikagaku Corp.
Active Substance(s):
SODIUM HYALURONATE
Strength:
10mg/ml
Pack size:
5 x 2.5ml Pre-Filled Syringes
About the product
Related products
CINGAL®
Hyaluronic acid
TRIAMCINOLONE HEXACETONIDE
249.00$
Tier pricing
Save 4.02%
3 or more
$239 each
Save 6.02%
11 or more
$234 each
Save 8.03%
21 or more
$229 each
CRESPINE® GEL PLUS
CROSS-LINKED HA
NON-CROSSLINKED HA
PRILOCAINE
139.00$
Tier pricing
Save 3.6%
3 or more
$134 each
Save 7.19%
11 or more
$129 each
Save 8.63%
21 or more
$127 each
HYALGAN® (Italian)
Sodum Hyaluronate
44.00$
Tier pricing
Save 2.27%
3 or more
$43 each
Save 4.55%
11 or more
$42 each
Save 9.09%
21 or more
$40 each
HYMOVIS® (German)
Hyaluronan
599.00$
Tier pricing
Save 1.67%
3 or more
$589 each
Save 2.5%
11 or more
$584 each
Save 3.34%
21 or more
$579 each
MONOVISC®
SODIUM HYALURONATE
349.00$
Tier pricing
Save 2.87%
3 or more
$339 each
Save 4.3%
11 or more
$334 each
Save 5.73%
21 or more
$329 each
ORTHOVISC®
Sodum Hyaluronate
52.00$
Tier pricing
Save 5.77%
3 or more
$49 each
Save 9.62%
11 or more
$47 each
Save 13.46%
21 or more
$45 each
SYNVISC®
HYLAN GF 20
329.00$
Tier pricing
Save 3.04%
3 or more
$319 each
Save 4.56%
11 or more
$314 each
Save 6.08%
21 or more
$309 each
DUROLANE®
SODIUM HYALURONATE
249.00$
Tier pricing
Save 4.02%
3 or more
$239 each
Save 6.02%
11 or more
$234 each
Save 8.03%
21 or more
$229 each
SUPARTZ FX is a hyaluronic acid (HA) multi-injection therapy proven to relieve knee pain in patients with mild to moderate osteoarthritis (OA).
SUPARTZ FX is indicated for treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen.
- Demonstrated improvements in knee pain and physical function at 6 months.
- Flexible dosing tailors therapy to each patient.
- Established safety profile similar to saline (placebo).
- SUPARTZ FX contains minimal impurities.
- Offers low-cost options for practices and patients.
SUPARTZ FX is a natural, non-opioid, FDA-approved therapy for knee osteoarthritis. It is created from highly purified animal-derived hyaluronic acid, to offer an unbeatable combination of effectiveness, dosing flexibility, and affordability. SUPARTZ FX is supplied as a sterile, non-pyrogenic solution in 2.5 mL pre-filled syringe.
- SUPARTZ FX is administered by intra-articular injection once a week (1 week apart) for a total of 5 injections.
- Some patients may experience benefit with 3 injections given at weekly intervals. This has been noted in a study in which patients treated with of subcutaneous lidocaine or similar local anesthetic may be recommended prior to injection of SUPARTZ FX.
Contraindications
Who should NOT have SUPARTZ therapy? People who:
- Are allergic to poultry and products from birds (such as feathers and eggs)
- Have infections or skin diseases in the area the injection will be given
- Have had any previous allergic reactions to SUPARTZ therapy or similar material, i.e., hyaluronate products.
- The safety and effectiveness of SUPARTZ therapy have not been established in pregnant women, lactating women, and children.
- Risks can include general knee pain, warmth and redness or pain at the injection site.
After-care
As with any invasive joint procedure, it is recommended that the patient avoid any strenuous activities or prolonged (i.e., more than 1 hour) weight-bearing activities such as jogging or tennis within the 48 hours that follow the intraarticular injection.
SUPARTZ FX is a hyaluronic acid (HA) multi-injection therapy proven to relieve knee pain in patients with mild to moderate osteoarthritis (OA).
SUPARTZ FX is indicated for treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen.
- Demonstrated improvements in knee pain and physical function at 6 months.
- Flexible dosing tailors therapy to each patient.
- Established safety profile similar to saline (placebo).
- SUPARTZ FX contains minimal impurities.
- Offers low-cost options for practices and patients.
SUPARTZ FX is a natural, non-opioid, FDA-approved therapy for knee osteoarthritis. It is created from highly purified animal-derived hyaluronic acid, to offer an unbeatable combination of effectiveness, dosing flexibility, and affordability. SUPARTZ FX is supplied as a sterile, non-pyrogenic solution in 2.5 mL pre-filled syringe.
- SUPARTZ FX is administered by intra-articular injection once a week (1 week apart) for a total of 5 injections.
- Some patients may experience benefit with 3 injections given at weekly intervals. This has been noted in a study in which patients treated with of subcutaneous lidocaine or similar local anesthetic may be recommended prior to injection of SUPARTZ FX.
Contraindications
Who should NOT have SUPARTZ therapy? People who:
- Are allergic to poultry and products from birds (such as feathers and eggs)
- Have infections or skin diseases in the area the injection will be given
- Have had any previous allergic reactions to SUPARTZ therapy or similar material, i.e., hyaluronate products.
- The safety and effectiveness of SUPARTZ therapy have not been established in pregnant women, lactating women, and children.
- Risks can include general knee pain, warmth and redness or pain at the injection site.
After-care
As with any invasive joint procedure, it is recommended that the patient avoid any strenuous activities or prolonged (i.e., more than 1 hour) weight-bearing activities such as jogging or tennis within the 48 hours that follow the intraarticular injection.
Products
Cart
Log In
Newsletter
Subscribe for exclusive offers and updates on new arrivals
[email protected]
Share feedback at:
[email protected]
Working Hours
Monday to Friday: 9 AM to 6 PM (EST)
Copyright 2024. Med Supply Solutions